ÃÖ±Ù 2³â°£ °ÔÀçµÈ ³í¹® Áß SCIE Àοë Ƚ¼ö °¡Àå ¸¹Àº ³í¹® 3Æí ¼±Á¤ÇØ ¼ö¿©
¼ö»ó ³í¹®Àº Äڷγª19 ¹ÙÀÌ·¯½º °¨¿°·®°ú ÀÎü Ç×ü»ý¼º·® º¯È Æò°¡ ¿¬±¸
2021³â KJIM 1¿ùÈ£ °ÔÀç ³í¹®À¸·Î, ÃÖ±Ù 2³â°£ SCIE Àοë Ƚ¼ö ÃÑ 39ȸ
[º¸°ÇŸÀÓÁî] ºÐ´ç¼¿ï´ëº´¿ø °¨¿°³»°ú ¼Û°æÈ£ ±³¼ö(»çÁø)ÀÇ ³í¹®ÀÌ ´ëÇѳ»°úÇÐȸ ‘2023³â KJIM ÃÖ´ÙÀÎ¿ë °ø·Î»ó’ ¼ö»óÀÚ¿¡ ¼±Á¤µÆ´Ù.
´ëÇѳ»°úÇÐȸ´Â ¸Å³â ÃÖ±Ù 2³â µ¿¾È ´ëÇѳ»°úÇÐȸ ¿µ¹® ÀâÁö ‘Korean Journal of Internal Medicine(KJIM)’¿¡ °ÔÀçµÈ ³í¹® Áß °úÇбâ¼ú ³í¹® Ãß°¡ ÀÎ¿ë »öÀÎ(SCIE)¿¡ ÀοëµÈ Ƚ¼ö°¡ °¡Àå ¸¹Àº ³í¹® 3ÆíÀ» ¼±Á¤ÇØ »óÀ» ¼ö¿©ÇÏ°í ÀÖ´Ù.
À̹ø¿¡ ¼ö»óÇÑ ³í¹®Àº ‘Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19’·Î, Äڷγª19ÀÇ °æ°ú¿¡ ´ëÇÑ °æÇè°ú ÀÌÇØ°¡ ºÎÁ·Çß´ø 2020³â Äڷγª19 ÆÒµ¥¹Í Ãʱâ, Äڷγª19 ¹ÙÀÌ·¯½ºÀÇ °¨¿°·®°ú ÀÎü Ç×ü »ý¼º·®¿¡ ´ëÇÑ º¯È¸¦ Æò°¡ÇÑ ¿¬±¸ °á°ú¸¦ ¹ßÇ¥ÇØ ÇаèÀÇ ÁÖ¸ñÀ» ¹Þ¾Ò´Ù.
ºÐ´ç¼¿ï´ëº´¿ø °¨¿°³»°ú ¼Û°æÈ£ ±³¼ö¿Í Á¶¼±´ëº´¿ø °¨¿°³»°ú ±èµ¿¹Î ±³¼ö°¡ Á¦1ÀúÀÚ, ºÐ´ç¼¿ï´ëº´¿ø °¨¿°³»°ú ±èÀǼ® ±³¼ö ±³½ÅÀúÀÚ·Î ¿¬±¸¿¡ Âü¿©ÇßÀ¸¸ç, ³í¹®Àº Áö³ 2021³â KJIM 1¿ùÈ£¿¡ °ÔÀçµÅ ÇöÀç±îÁö ÃÑ 39ȸ ÀοëµÆ´Ù.
ÇÑÆí, ¼Û°æÈ£ ±³¼ö´Â ¼¿ï´ëº´¿ø °¨¿°³»°ú ¹Ú¿Ï¹ü ±³¼ö¿Í ÇÔ²² ´ëÇѳ»°úÇÐȸÁö¿¡ °ÔÀçÇÑ ³í¹® ‘Can reactogenicity predict immunogenicity after COVID-19 vaccination?’À¸·Î ´ëÇѳ»°úÇÐȸ 2021³â ÇϹݱ⠿ì¼ö³í¹®À¸·Î ¼±Á¤µÈ ¹Ù ÀÖÀ¸¸ç, 2022³â ´ëÇÑ°¨¿°ÇÐȸ-´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ‘´ëÇÑ°¨¿°ÇÐȸ-Institut Mérieux ÀþÀº °úÇÐÀÚ»ó’°ú ‘¿ì¼ö³í¹®»ó’À» ¼ö»óÇϱ⵵ Çß´Ù.